Aaron Wealth Advisors LLC boosted its stake in shares of Relx Plc (NYSE:RELX – Free Report) by 9.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 16,919 shares of the technology company’s stock after purchasing an additional 1,503 shares during the quarter. Aaron Wealth Advisors LLC’s holdings in Relx were worth $768,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of RELX. JPMorgan Chase & Co. lifted its holdings in Relx by 14.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock worth $39,225,000 after purchasing an additional 104,999 shares during the last quarter. CWA Asset Management Group LLC acquired a new stake in shares of Relx during the third quarter worth $548,000. Creative Planning lifted its holdings in shares of Relx by 16.4% during the second quarter. Creative Planning now owns 128,930 shares of the technology company’s stock worth $5,915,000 after buying an additional 18,199 shares in the last quarter. International Assets Investment Management LLC bought a new stake in shares of Relx in the third quarter valued at about $1,268,000. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Relx by 13.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 120,300 shares of the technology company’s stock valued at $5,709,000 after acquiring an additional 14,088 shares in the last quarter. 15.02% of the stock is currently owned by institutional investors and hedge funds.
Relx Price Performance
RELX opened at $48.18 on Monday. The business’s fifty day moving average is $46.44 and its 200-day moving average is $46.59. Relx Plc has a 52-week low of $40.25 and a 52-week high of $48.91.
Wall Street Analysts Forecast Growth
Read Our Latest Analysis on RELX
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories
- Five stocks we like better than Relx
- What Are Dividend Champions? How to Invest in the Champions
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Stock Market Sectors: What Are They and How Many Are There?
- Oilfield Leader SLB: An AI Name You Need to Know
- The 3 Best Retail Stocks to Shop for in August
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.